Product Categories
| Country: | China |
|---|---|
| Tel: | 0531-88723173 |
| Mobile: | 18596073690 |
| E-mail: | |
| QQ: | |
| Skype: | Chat Now! |
| Product Name | MF | CAS | Details |
|---|
| 4-(2-fluorobenzyloxy)-3-chlorobenzenamine | C13H11ClFNO | 179246-45-8 | Details |
| Mexiletine Hydrochloride EP Impurity C | C22H32N2O2 | 2059988-38-2 | Details |
| L-alanyl-L-Glutamine | C8H15N3O4 | 39537-23-0 | Details |
| Dabigatran | C25H25N7O3 | 211914-51-1 | Details |
| PSMA-HBED-CC | C44H62N6O17 | 1366302-52-4 | Details |
| Mexiletine EP impurity B | C11H14O2 | 53012-41-2 | Details |
| Etoricoxib Impurity 7 | C18H15ClN2O3S | 325855-74-1 | Details |
| Isaconazole sulfate impurity | C7H16N2O | 3813-27-2 | Details |
| Isaconazole sulfate impurity | C15H12ClN3O4 | 17714-02-2 | Details |
| Isaconazole sulfate impurity | C13H15NO6 | 374816-32-7 | Details |
| Isaconazole sulfate impurity | C10H7F2N3O | 168479-96-7 | Details |
| Isaconazole sulfate impurity | C3H6N2O3 | 72078-82-1 | Details |
| Isaconazole sulfate impurity | C8H5Br2N | 67013-55-2 | Details |
| Isaconazole sulfate impurity | C10H8FN3O | 128136-94-7 | Details |
| Isaconazole sulfate impurity | C7H11NO | 5632-84-8 | Details |
| Isaconazole sulfate impurity | 38246-95-6 | Details |
| Isaconazole sulfate impurity | C3H5N3O3 | 2148-09-6 | Details |
| Voriconazole genotoxic impurity 3 | Details |
| Furosemide photodegrades Impurity III | C12H12N2O6S | 133989-65-8 | Details |
| Cyclopenta[5,6]naphtho[2,1-b]pyran-7-carboxylic acid, 2,3,4,4a,4b,5,6,6a,7,8,9,9a,9b,10-tetradecahydro-4a,6a-dimethyl-2-oxo-, methyl ester, (4aR,4bS,6aS,7S,9aS,9bS)- | C20H28O4 | 153222-81-2 | Details |
| Adrenaline EP Impurity F | C9H13NO5S | 26405-77-6 | Details |
| Tofacitinib Impurity | C14H20N6O | 1640971-60-3 | Details |
| Isaconazole sulfate impurity 1 | Details |
| Englitazin hydroxybutyric acid impurity | Details |
| Isaconazole sulfate impurity 7 | Details |
| Isaconazole sulfate impurity5 | Details |
| Pregabalin Impurity 19 | C11H14O3 | 89015-27-0 | Details |
| Rosastat impurity | C19H16N2O5 | 2301113-15-3 | Details |
| Esomeprazole Impurity 96 | C9H11NO2 | 110464-72-7 | Details |
| 5-[[4-[(2,3-DiMethyl-2H-indazol-6-yl)aMino]-2-pyriMidinyl]aMino]-2-MethylbenzenesulfonaMide | C20H21N7O2S | 1252927-47-1 | Details |
| Pazopanib | C21H23N7O2S | 444731-52-6 | Details |
| Etoricoxib Impurity 7 | C20H21N3O2S | 646459-39-4 | Details |
| N-DesmethylApalutamide | C21H16F3N5O2S | 1332389-57-7 | Details |
| tert-Butyl Tosylate DISCONTINUED | C11H16O3S | 4664-57-7 | Details |
| Fulvestrant Impurity gyl | C10H12F10S2 | 1688657-00-2 | Details |
| 1H-1,2,3-Triazole | C2H3N3 | 288-36-8 | Details |
| 4-sulfobenzenediazonium,chloride | C6H5ClN2O3S | 6118-33-8 | Details |
| N1,N2-bis[[(S)-3-[3-fluoro-4-(4-morpholinyl)phenyl]-2-oxo-5-oxazolidinyl]methyl]phthalamide | Details |
| 6-Aminoquinolyl-N-hydroxysuccinimidylcarbamate | C14H11N3O4 | 148757-94-2 | Details |
| 1,3-Bis[[(S)-3-[3-fluoro-4(4-morpholino)phenyl]-2-oxo-5-oxazolidinyl]methyl]urea | Details |
| (S)-N-((3-(3-fluoro-4-morpholinylphenyl)-2-oxy-5-oxazolidinyl)methyl)-N-methylacetamide | Details |
| N-[(2R)-3-[[3-Fluoro-4-(4-Morpholinyl)phenyl]aMino]-2-hydroxypropyl]acetaMide | C15H22FN3O3 | 333753-67-6 | Details |
| Linezolid N-Oxide | C16H20FN3O5 | 189038-36-6 | Details |
| 2-Azabicyclo[3.1.0]hexane-3-carbonitrile, 2-[(2R)-2-aMino-2-(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)acetyl]-, (1R,3S,5R)- | C18H25N3O2 | 1564265-98-0 | Details |
| 2-Azabicyclo[3.1.0]hexane-3-carbonitrile, 2-[(2R)-2-aMino-2-(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)acetyl]-, (1S,3S,5S)- | C18H25N3O2 | 1564265-93-5 | Details |
| 2-Azabicyclo[3.1.0]hexane-3-carbonitrile, 2-[(2S)-2-aMino-2-(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)acetyl]-, (1R,3R,5R)- | C18H25N3O2 | 1564265-94-6 | Details |
| 5-Pyrimidinol, 1-[3-fluoro-4-(4-morpholinyl)phenyl]-1,4,5,6-tetrahydro-2-methyl- | C15H20FN3O2 | 2512211-93-5 | Details |
| 2-Azabicyclo[3.1.0]hexane-3-carbonitrile, 2-[(2R)-2-aMino-2-(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)acetyl]-, (1R,3R,5R)- | C18H25N3O2 | 1564265-95-7 | Details |
| Saxagliptin | C18H25N3O2 | 361442-04-8 | Details |
| Saxagliptin Impurity | C18H24ClN3O2 | 2173146-35-3 | Details |
| 2-CYANO-N-P-TOLYL-ACETAMIDE | C10H10N2O | 6876-54-6 | Details |
| Nifedipine Impurity L | Details |
| Aprepitant EP Impurity B | C29H25F7N4O3 | 2206606-86-0 | Details |
| 1-(thiophen-2-yl)prop-2-en-1-ol | C7H8OS | 393148-57-7 | Details |
| 7-ethyl-5H-chroMeno[2,3-b]pyridin-5-one | C14H11NO2 | 53944-31-3 | Details |
| [(2R,3S,4R,5R)-5-acetamido-2,3,4-trihydroxy-6-oxo-hexoxy]phosphonic acid | C8H16NO9P | 1746-32-3 | Details |
| Epiclindamycin Palmitate | Details |
| desulfomethyl clindamycin | Details |
| Paliperidone Z-Oxime | C23H28F2N4O3 | 1388021-47-3 | Details |
| Carbamic acid, N-[(1S)-1-methyl-2-oxo-2-[3-(phenylmethoxy)phenyl]ethyl]-, phenylmethyl ester | C24H23NO4 | 2151127-61-4 | Details |
| Carbamic acid, [2-hydroxy-1-methyl-2-[3-(phenylmethoxy)phenyl]ethyl]-, phenylmethyl ester, [R-(R*,S*)]- (9CI) | C24H25NO4 | 31301-86-7 | Details |
| 1,5-Pentanedione, 1-(2-fluorophenyl)-5-[(4S)-2-oxo-4-phenyl-3-oxazolidinyl]- | C20H18FNO4 | 2514695-40-8 | Details |
| 2,4-DIHYDROXY-3,3-DIMETHYLBUTANOIC ACID | C6H12O4 | 470-29-1 | Details |
| 2-ENEVALPROIC ACID | C8H14O2 | 60218-41-9 | Details |
| Methylergometrinine Impurity E | Details |
| Methylergometrinine Impurity A | Details |
| Methylergometrinine Impurity I | Details |
| Cimetidine EP Impurity C | C10H17N6OS | 52568-80-6 | Details |
| Phenylmethyl methanesulfonate | C8H10O3S | 55791-06-5 | Details |
| 6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxylic acid methyl ester | C9H15NO2 | 1933760-32-7 | Details |
| Febuxostat Descyano Impurity | C15H17NO3S | 1206550-99-3 | Details |
| Febuxostat impurity BAC | Details |
| Febuxostat impurity DAC | Details |
| Febuxostat impurity EOX | Details |
| 2-[3-Carboxy-4-(2-Methylpropoxy)phenyl]-4-Methyl-5-thiazolecarboxylic Acid | C16H17NO5S | 1239233-87-4 | Details |
| 4,5,6,7-Tetrahydro-thieno[3,2-c]pyridin-2-ol 2-acetate | C9H11NO2S | 1151904-85-6 | Details |
| Tofacitinib Impurity HC1309-323 | Details |
| Dipyridamole EP Impurity B | C23H40N8O6 | 16908-47-7 | Details |
| Dipyridamole EP Impurity F | C21H36N8O5 | 60286-30-8 | Details |
| Dolutegravir RR isomer | C20H19F2N3O5 | 1357289-29-2 | Details |
| Dipyridamole EP Impurity C | C20H30ClN7O2 | 54093-92-4 | Details |
| Dipyridamole EP Impurity D | C22H36N8O3 | 1176886-12-6 | Details |
| ISOBUTYROHYDROXAMIC ACID | C4H9NO2 | 22779-89-1 | Details |
| Sodium Valproate EP Impurity G | C11H23NO | 52061-73-1 | Details |
| Dolutegravir SR isomer | C20H19F2N3O5 | 1309560-49-3 | Details |
| Trelagliptin Succinate Dimer Impurity | Details |
| (R) - oracetam | C6H10N2O3 | 65252-28-6 | Details |
| Mesartan potassium impurity AEQ | C35H28N4O11 | 1604812-35-2 | Details |
| Ticagrelor intermediate | C10H9F2NO | 1006376-62-0 | Details |
| Thymus method new impurity I | Details |
| Ticagrelor impurity 30 | C7H9Cl2N3OS | 1823431-32-8 | Details |
| Viagliptin impurity R | C7H8Cl2N2O | 1803168-09-3 | Details |
| 2,4-dioxopyrrolidine-1-acetamide | C6H8N2O3 | 85614-54-6 | Details |
| Formoterol impurity | C18H24ClNO | 934685-45-7 | Details |
| Telmisartan impurity B | C33H30N4O2 | 1026353-20-7 | Details |
| Lysophosphatidylcholine (soybean) | C24H50NO7P | 97281-38-4 | Details |
| Esmolol dimer | C31H46N2O7 | 98903-89-0 | Details |
| Avana non impurity | C18H17ClN6O3 | 1452128-53-8 | Details |
| Tofacitinib Impurity gyl | C32H40N12O2 | 2102040-00-4 | Details |
| N-methyl-1-phenethylamine | C9H13N | 32512-24-6 | Details |
| Product Total： Product Page： | ||||
| 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 | ||||